These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2076571)

  • 1. Synthesis of 2-[[(4-fluoroalkoxy-2-pyridyl)methyl]sulfinyl]-1H- benzimidazoles as antiulcer agents.
    Kubo K; Oda K; Kaneko T; Satoh H; Nohara A
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2853-8. PubMed ID: 2076571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
    Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H; Inatomi N; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
    Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
    Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
    Coruzzi G; Adami M; Bertaccini G
    Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
    Morini G; Grandi D; Arcari ML; Bertaccini G
    Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats.
    Goto H; Sugiyama S; Tsukamoto Y; Kuroiwa M; Ohara A; Hoshino H; Nakazawa S; Ozawa T
    Arzneimittelforschung; 1991 Jun; 41(6):635-7. PubMed ID: 1657010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiulcer activities of novel 2-[(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H- benzimidazole analogues.
    Yamada S; Goto T; Shimanuki E; Narita S
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):718-20. PubMed ID: 8004722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
    Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
    Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the gastroprotective activity of cordatin, a diterpene isolated from Aparisthmium cordatum (Euphorbiaceae).
    Hiruma-Lima CA; Gracioso JD; Toma W; de Paula AC; de Almeida AB; Brasil DD; Muller AH; Brito AR
    Biol Pharm Bull; 2000 Dec; 23(12):1465-9. PubMed ID: 11145179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and synthesis of potential impurities of rabeprazole sodium.
    Pingili RR; Jambula MR; Ganta MR; Ghanta MR; Sajja E; Sundaram V; Boluggdu VB
    Pharmazie; 2005 Nov; 60(11):814-8. PubMed ID: 16320941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
    Tsuji S; Sun WH; Tsujii M; Kawai N; Kimura A; Kakiuchi Y; Yasumaru S; Komori M; Murata H; Sasaki Y; Kawano S; Hori M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1301-8. PubMed ID: 12438555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
    Nagaya H; Inatomi N; Nohara A; Satoh H
    Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
    Bergmann JF; Chassany O; Simoneau G; Lemaire M; Segrestaa JM; Caulin C
    Clin Pharmacol Ther; 1992 Oct; 52(4):413-6. PubMed ID: 1424414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
    Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
    Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.